Recent Acutus Stock Market Announcement November, 2023
On November 8, 2023, Acutus Medical announced they will immediately begin winding down manufacturing and distribution of the AcQMap 3D Mapping System, the AcQMap/SentiCath 3D Mapping Catheter, the AlCath Force Catheters, the Qubic Force, the AcQGuide/Adnovo Max 2.0 steerable sheath, and associated accessories. According to the company statement this is driven by challenges in the current financing environment.
BIOTRONIK, as the distribution partner of Acutus in many countries around the world, deeply regrets this decision. BIOTRONIK had not been informed in advance of this development. We will evaluate the consequences of this unexpected development and any potential mitigating actions available to us.
Our key priority is to support our customers and mitigate the consequences these changes may have on their practice and patients to the best of our abilities under the circumstances.
We, as BIOTRONIK, will continue to support AcQMap procedures as long as inventory is available and Acutus Medical fulfills its obligations as the legal manufacturer.
Acutus Medical´s decision does not affect the availability and supply of BIOTRONIK´s own EP portfolio. We will continue to invest and develop our unique solutions for diagnostic and ablation catheters, transseptal access tools, accessories and external EP devices.
About BIOTRONIK:
At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries.